NASDAQ · RXRX
Recursion Pharmaceuticals, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for RXRX: Nov 4, 2026
Recursion Pharmaceuticals, Inc. Class A Common Stock is estimated to report earnings on 11/04/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.24. The reported EPS for the same quarter last year was $-0.36.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.24 | $-0.23 | $-0.25 | 3 |
| Dec 2026 | $-0.21 | $-0.18 | $-0.23 | 2 |
| Mar 2027 | $-0.17 | $-0.17 | $-0.17 | 1 |
| Jun 2027 | $-0.18 | $-0.18 | $-0.18 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · BNK Invest- Zacks · Oct 29, 9:22 AM EDTRecursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?RXRX heads into Q3 earnings with key collaboration milestones, advancing clinical programs and upcoming pipeline updates that could shape its outlook.
- Zacks · Oct 29, 9:00 AM EDTZymeworks Inc. (ZYME) to Report Q3 Results: Wall Street Expects Earnings GrowthZymeworks (ZYME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 28, 9:00 AM EDTRecursion Pharmaceuticals (RXRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseRecursion Pharmaceuticals (RXRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 27, 7:55 AM EDTWhy Investors Need to Take Advantage of These 2 Medical Stocks NowWhy investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Zacks · Oct 26, 4:50 PM EDTRecursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to ConsiderRecursion Pharmaceuticals (RXRX) concluded the recent trading session at $3.8, signifying a +2.7% move from its prior day's close.
- Zacks · Oct 20, 4:50 PM EDTRecursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth KnowingRecursion Pharmaceuticals (RXRX) reached $3.66 at the closing of the latest trading day, reflecting a +1.39% change compared to its last close.
- RTTNews · Oct 15, 10:55 AM EDTRecursion To Receive $10 Mln Milestone Payment As Sanofi Selects Immunology Drug Candidate(RTTNews) – Recursion Pharmaceuticals Inc. (RXRX) announced Thursday that Sanofi (SNY) has selected the first development candidate under their research collaboration, triggering a $10 million milestone payment to Recursion.
- RTTNews · Oct 15, 10:08 AM EDTRecursion Pharmaceuticals Prices Offering Of 61.54 Mln Shares At $3.25/Shr(RTTNews) – On Thursday, Recursion Pharmaceuticals (RXRX) priced an offering of 61.54 million Class A shares at $3.25 each, expecting to raise approximately $200 million before expenses.
- Zacks · Oct 12, 4:50 PM EDTRecursion Pharmaceuticals (RXRX) Registers a Bigger Fall Than the Market: Important Facts to NoteRecursion Pharmaceuticals (RXRX) closed the most recent trading day at $4.01, moving 8.03% from the previous trading session.
- Zacks · Oct 12, 10:46 AM EDTTempus AI Expands Strategic Collaborations to Drive Future GrowthTEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future revenue growth.
- BNK Invest · Oct 8, 12:01 PM EDTThursday Sector Laggards: Biotechnology, Packaging & ContainersIn trading on Thursday, biotechnology shares were relative laggards, down on the day by about 2.4%. Helping drag down the group were shares of Caribou Biosciences, down about 19.3% and shares of Recursion Pharmaceuticals off about 9% on the day. Also lagging the market Thursda
- Zacks · Oct 6, 4:50 PM EDTRecursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for InvestorsThe latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.63, representing a -3.14% change from its previous close.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Recursion Pharmaceuticals, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.